Article
AGR2-Dependent Nuclear Import of RNA Polymerase II Constitutes a Specific Target of Pancreatic Ductal Adenocarcinoma in the Context of Wild-Type p53.
Gastroenterology - 1 Nov 2021
Zhang Zhiheng, Li Hongzhen, Deng Yibin, Schuck Kathleen, Raulefs Susanne, Maeritz Nadja, Yu Yuanyuan, Hechler Torsten, Pahl Andreas, Fernández-Sáiz Vanesa, Wan Yuan, Wang Guosheng, Engleitner Thomas, Öllinger Rupert, Rad Roland, Reichert Maximilian, Diakopoulos Kalliope N, Weber Verena, Li Jingjing, Shen Shanshan, Zou Xiaoping, Kleeff Jörg, Mihaljevic Andre, Michalski Christoph W, Algül Hana, Friess Helmut, Kong Bo
Abstract excerpt
BACKGROUND & AIMS: Promoted by pancreatitis, oncogenic KrasG12D triggers acinar cells' neoplastic transformation through acinar-to-ductal metaplasia (ADM) and pancreatic intraepithelial neoplasia. Anterior gradient 2 (Agr2), a known inhibitor of p53, is detected at early stage of pancreatic ductal adenocarcinoma (PDAC) development. RNA polymerase II (RNAPII) is a key nuclear enzyme; regulation of its nuclear...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
